Is Ultragenyx Pharmaceutical, Inc. RARE stock halal to invest in?

No, as of August 2026, Ultragenyx Pharmaceutical, Inc. stock (RARE) is not currently classified as a Shariah compliant stock. This verdict follows the screening methodology of AAOIFI (the Accounting and Auditing Organization for Islamic Financial Institutions), whose Shariah Standard No. 21 is the leading global benchmark for screening halal stocks. To qualify as halal under this standard, a company must keep non-permissible income below 5% of total revenue, keep both interest-bearing investments and interest-bearing debt below 30% of market capitalisation, and have no impermissible preference share structure. Ultragenyx Pharmaceutical, Inc. currently does not meet the threshold for the interest-bearing debt screen. Because screenings are refreshed monthly as new financial reports are published, a non-compliant stock can regain compliant status if its financial structure changes. You can track the latest status of Ultragenyx Pharmaceutical, Inc. and discover Shariah compliant alternatives among the halal stocks in the Tabadulat app.

How often is Ultragenyx Pharmaceutical, Inc. RARE reviewed for Shariah compliance?

Tabadulat reviews Ultragenyx Pharmaceutical, Inc. RARE for Shariah compliance every month. Each review applies the AAOIFI Shariah Standard No. 21 methodology, screening the company's business activities, non-permissible income, interest-bearing investments, interest-bearing debt, and preference shares, against the company's latest available financial data. The process operates under the direct supervision of Tabadulat's dedicated Shariah Supervisory Board of Islamic finance scholars. Because compliance depends on financial ratios that move with market capitalisation and reported results, a stock's status can change from one review to the next. Monthly screening ensures the status shown for Ultragenyx Pharmaceutical, Inc. reflects current financial data rather than an outdated assessment, and Tabadulat app users are notified if a holding in their portfolio becomes non-compliant.

Does Ultragenyx Pharmaceutical, Inc. RARE pass the AAOIFI Non Permissible Income criteria?

Yes, as of August 2026, Ultragenyx Pharmaceutical, Inc. stock (RARE) passes the AAOIFI non-permissible income screen. Under AAOIFI Shariah Standard No. 21, income from impermissible sources (such as interest or riba, conventional financial services, alcohol, gambling, or tobacco) must remain below 5% of a company's total revenue. Ultragenyx Pharmaceutical, Inc.'s income from non-permissible sources is currently within this 5% threshold. Even permissible levels of incidental impure income should still be purified: investors donate the corresponding share of dividends to charity, as reflected in the stock's purification factor. This screen is reassessed monthly using the company's latest financial disclosures.

Does Ultragenyx Pharmaceutical, Inc. RARE pass the AAOIFI Interest Bearing Investments criteria?

Yes, as of August 2026, Ultragenyx Pharmaceutical, Inc. stock (RARE) passes the AAOIFI interest-bearing investments screen. Under AAOIFI Shariah Standard No. 21, the cash a company places in interest-earning instruments (such as conventional deposits, bonds, treasury bills and money-market funds) must remain below 30% of its market capitalisation. This limit ensures shareholders are not materially profiting from riba (interest). Ultragenyx Pharmaceutical, Inc.'s interest-bearing investments are currently within the 30% threshold. Because the ratio is measured against market capitalisation, it can move with the share price as well as the balance sheet, which is why Tabadulat rescreens the stock every month.

Does Ultragenyx Pharmaceutical, Inc. RARE pass the AAOIFI Interest Bearing Debt criteria?

No, as of August 2026, Ultragenyx Pharmaceutical, Inc. stock (RARE) does not pass the AAOIFI interest-bearing debt screen. Under AAOIFI Shariah Standard No. 21, a company's borrowings that accrue interest (conventional bank loans, bonds and similar riba-based financing) must remain below 30% of its market capitalisation. Ultragenyx Pharmaceutical, Inc.'s interest-bearing debt currently exceeds this 30% limit, meaning the company relies on riba-based financing beyond the level AAOIFI permits for a halal investment. A company can return to compliance by reducing debt or through changes in market capitalisation, and the screen is reassessed monthly.

What is the dividend purification factor for Ultragenyx Pharmaceutical, Inc. RARE stock?

Ultragenyx Pharmaceutical, Inc. (RARE) is currently classified as not Shariah compliant, so no dividend purification factor applies, because purification factors are calculated only for stocks that pass the AAOIFI screens. Purification (tazkiyah) is the practice of donating to charity the small portion of dividend income that stems from incidental non-permissible sources, such as interest earned on a compliant company's cash deposits. For non-compliant stocks the issue is not purification but eligibility: under AAOIFI Shariah Standard No. 21 the stock does not currently qualify as a halal investment. If Ultragenyx Pharmaceutical, Inc. returns to compliance in a future monthly screening, its purification factor will be published alongside its updated status in the Tabadulat app.

Does Ultragenyx Pharmaceutical, Inc. RARE pass the AAOIFI Preference Share screen?

Yes, as of August 2026, Ultragenyx Pharmaceutical, Inc. stock (RARE) passes the AAOIFI preference share screen. AAOIFI Shariah Standard No. 21 prohibits investing in preference shares because they grant holders guaranteed or priority rights to dividends and capital ahead of ordinary shareholders, a structure that conflicts with the Shariah principle that investors should share profit and loss in proportion to their ownership. Ultragenyx Pharmaceutical, Inc. has no impermissible preference share structure affecting its ordinary shares, so the stock is compliant on this criterion. Like all AAOIFI screens, this is verified in each monthly review.

Invest Halal, Anytime, Anywhere

Download the Tabadulat app and start building your Shariah-compliant portfolio in minutes.

English

العربية

Ultragenyx Pharmaceutical, Inc.

NASDAQ

Shariah-Compliant

Not Shariah

RARE

About

Ultragenyx Pharmaceutical, Inc.

RARE

Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company that focuses on the development and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases. The company's primary function is to address unmet medical needs by working on advanced treatments targeting conditions that often lack effective therapies. Ultragenyx is primarily involved in the biotechnology sector, impacting areas such as gene therapy, small molecule drugs, and advanced biologic therapies. The company engages in various stages of product development, from clinical trials to commercialization, emphasizing collaboration with academic institutions and other pharmaceutical companies. Its innovative approaches leverage genetic information to develop tailored treatments, aiming to improve patients' quality of life. Ultragenyx’s market significance lies in its specialized focus, contributing to therapeutics that typically see less attention due to smaller patient populations. Founded in 2010 and headquartered in Novato, California, Ultragenyx continues to play a crucial role in the biopharmaceutical industry by pushing boundaries in niche markets and focusing on precision medicine for rare genetic disorders.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

1294

Website:

https://www.ultragenyx.com

RARE

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Open your account.

Create your Tabadulat account in minutes: enter your details, complete identity verification, and add funds by secure transfer in multiple currencies. You're ready to start investing in halal stocks the same day.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Ultragenyx Pharmaceutical, Inc.

About

Ultragenyx Pharmaceutical, Inc.

RARE

Frequently asked questions

Is Ultragenyx Pharmaceutical, Inc. RARE stock halal to invest in?

How often is Ultragenyx Pharmaceutical, Inc. RARE reviewed for Shariah compliance?

Does Ultragenyx Pharmaceutical, Inc. RARE pass the AAOIFI Non Permissible Income criteria?

Does Ultragenyx Pharmaceutical, Inc. RARE pass the AAOIFI Interest Bearing Investments criteria?

Does Ultragenyx Pharmaceutical, Inc. RARE pass the AAOIFI Interest Bearing Debt criteria?

What is the dividend purification factor for Ultragenyx Pharmaceutical, Inc. RARE stock?

Does Ultragenyx Pharmaceutical, Inc. RARE pass the AAOIFI Preference Share screen?

Can I buy Ultragenyx Pharmaceutical (RARE) stock on Tabadulat?

Open your account.

Deposit.

Screen.